Since January, when the World Health Organization (WHO) announced that it had identified a new virus and declared its outbreak a public health emergency of international concern, COVID-19 has dominated headlines—and our daily lives.
There is much we have learned about the novel coronavirus, also known as SARS-CoV-2, since then—and much public health experts continue to untangle about the virus seemingly every day.
Is it mutating? Does warmer weather have any impact on its spread? Are men and women getting sick in the same way?
Researchers around the world, including those at Johnson & Johnson, are exploring some of these questions as they work hard on identifying investigational vaccine candidates.
Want to test your own COVID-19 know-how? Take our quiz—and learn more about what it might take to help fight the pandemic.
There is much we have learned about the novel coronavirus, also known as SARS-CoV-2, since then—and much public health experts continue to untangle about the virus seemingly every day.
Is it mutating? Does warmer weather have any impact on its spread? Are men and women getting sick in the same way?
Researchers around the world, including those at Johnson & Johnson, are exploring some of these questions as they work hard on identifying investigational vaccine candidates.
Want to test your own COVID-19 know-how? Take our quiz—and learn more about what it might take to help fight the pandemic.
More From Johnson & Johnson
She’s a scientist with one of the world’s most important jobs: Creating a potential COVID-19 vaccine
Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D.
6 impactful ways Johnson & Johnson is helping in the fight against COVID-19
From work on an investigational vaccine candidate to a $50 million commitment in support of healthcare workers on the very front lines of the crisis around the world, learn how the company has taken action to help respond to the pandemic.
“I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
